about
MicroRNA and Heart FailureMicroRNAs Based Therapy of Hypertrophic Cardiomyopathy: The Road Traveled So FarAerobic exercise training promotes physiological cardiac remodeling involving a set of microRNAsTranscriptome complexity in cardiac development and diseases--an expanding universe between genome and phenomemiR-185 plays an anti-hypertrophic role in the heart via multiple targets in the calcium-signaling pathwaysEpidemiology of left ventricular hypertrophy in hypertension: implications for the clinic.Integrated microRNA and messenger RNA analysis in aortic stenosis.Systemic approach to identify serum microRNAs as potential biomarkers for acute myocardial infarction.Circulating level of miR-378 predicts left ventricular hypertrophy in patients with aortic stenosisDeficiency of cardiomyocyte-specific microRNA-378 contributes to the development of cardiac fibrosis involving a transforming growth factor β (TGFβ1)-dependent paracrine mechanism.RNA expression profiling of human iPSC-derived cardiomyocytes in a cardiac hypertrophy model.Common variation neighbouring micro-RNA 22 is associated with increased left ventricular massA panel of 4 microRNAs facilitates the prediction of left ventricular contractility after acute myocardial infarction.Integromics network meta-analysis on cardiac aging offers robust multi-layer modular signatures and reveals micronome synergism.MiRNAs with apoptosis regulating potential are differentially expressed in chronic exercise-induced physiologically hypertrophied hearts.Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophyLong Non-Coding RNA-ROR Mediates the Reprogramming in Cardiac Hypertrophy.Exploring Regulatory Mechanisms of Atrial Myocyte Hypertrophy of Mitral Regurgitation through Gene Expression Profiling Analysis: Role of NFAT in Cardiac HypertrophyMicroRNA: A new therapeutic strategy for cardiovascular diseases.miR-218 Involvement in Cardiomyocyte Hypertrophy Is Likely through Targeting REST.Overexpression of miR-223 Tips the Balance of Pro- and Anti-hypertrophic Signaling Cascades toward Physiologic Cardiac Hypertrophy.Identification and comparative analyses of myocardial miRNAs involved in the fetal response to maternal obesity.Circulating levels of miR-133a predict the regression potential of left ventricular hypertrophy after valve replacement surgery in patients with aortic stenosis.MicroRNA basis of physiological hypertrophy.Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophyInvolvement of microRNA-133 and -29 in cardiac disturbances in diabetic ovariectomized ratsCirculating microRNAs as potential biomarkers of aerobic exercise capacity.Epigenetics and chromatin remodeling in adult cardiomyopathy.MicroRNAs in heart failure: new targets in disease management.Cardiovascular extracellular microRNAs: emerging diagnostic markers and mechanisms of cell-to-cell RNA communication.The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy.Missing links in cardiology: long non-coding RNAs enter the arena.Antisense MicroRNA Therapeutics in Cardiovascular Disease: Quo Vadis?A Systems Biology Approach to Investigating Sex Differences in Cardiac Hypertrophy.MicroRNA-140 is elevated and mitofusin-1 is downregulated in the right ventricle of the Sugen5416/hypoxia/normoxia model of pulmonary arterial hypertension.Low Levels of MicroRNA-21 Are a Marker of Reduced Arterial Stiffness in Well-Controlled Hypertension.The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.Kruppel-like factor 4 protein regulates isoproterenol-induced cardiac hypertrophy by modulating myocardin expression and activity.MicroRNA-1 overexpression blunts cardiomyocyte hypertrophy elicited by thyroid hormone.The Role of MicroRNAs in the Cardiac Response to Exercise.
P2860
Q26750638-41D5CB06-0A25-4BFC-B9F0-953DB9CCB295Q26778555-953B4EC2-0DCF-41AF-8656-9E1D71253DBBQ26827482-807C51BF-65B5-424C-9548-1D38CB712E57Q27027884-B2CBDB19-7546-4CA5-B36F-BC858D95127FQ28544014-E6E56203-96BC-4192-B0FC-8EF04D8CFD50Q30250365-9F0F63C0-CBF6-4677-BA5E-8DBA6B9C89B7Q30829479-ACA5F498-7036-4F3A-824E-3427F125170AQ33677280-5C2A297B-28EE-4275-A859-D57D7BCD2D39Q34089884-8A5F34F6-FB46-438A-B3A7-4458DA8CEE31Q34245123-03D37F9D-25AC-4C48-8711-8C63D2187C25Q34257330-5411D847-EF2C-4AB9-B105-AC6E4C8AD343Q34571542-FED173E0-207B-4EAA-94C5-313D51C74882Q34962538-B11033B1-3CC7-4EFD-9957-23FF7B239824Q35200924-8867D4E7-9A10-4783-B21F-65A4181B6999Q35202826-1765C79A-0E4F-46F4-B782-83CDCAF2F5B7Q35206519-0BA41B7E-6FE5-4A01-9ABB-5E428D7C8164Q35991214-48E14753-3545-48DF-9969-CAF7BEA877ACQ36209703-7631F5DF-4247-40D8-8C7A-4B1C665C8DC5Q37017196-518E41A2-D5B4-4A91-B09B-063295ABFE1FQ37050572-41F04B4D-7F0C-49F2-923E-E645E57A03ADQ37117314-AC9C573D-6DF0-4F67-B952-62A77F922F24Q37234922-76EA50E4-5927-4332-8555-F700D4FDEE8CQ37310442-AB064F3F-0F09-406E-99F6-717D3E71A244Q37342263-57952540-CD33-46CF-8225-A059C1D82D7CQ37380034-04C5B12A-2F8D-4EC9-B354-8917C99971F4Q37447697-38C64DA5-9D9B-457D-B016-688A62B61E98Q37576146-11502FB0-4BFD-47E1-A325-EC6C95E19743Q38118214-421E0791-A532-424F-A5EB-B057123D66AFQ38121484-A9ABD635-D737-47C0-A8D8-1B821A1C1D91Q38165939-4F05ECD9-F078-49BF-8C5E-E5AC2037D607Q38182139-64B9EE2A-6314-402F-99E0-2E795974965CQ38195224-A7B76276-3221-4971-A580-91889C0ADF2AQ38555602-B04AC6DD-AC3D-434D-AE29-B415E268B47FQ38597918-28AD0CA4-2E8A-4BE7-8CFC-8421D59DEC00Q38757844-5192F638-5BED-492B-B479-1F91A986EF99Q38828855-51515680-D05F-43D3-B26D-C57D8A26DCD3Q38941373-F82115DB-142E-4558-B3FD-F1C535BEFF48Q38968198-7C0AFCD2-690C-4419-813F-E2BB9B3C8793Q39034552-225C9448-9476-4BD4-A2D1-E8540236606CQ39227661-21B7661F-DB3F-490F-85E3-5EE81361D53C
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
MicroRNAs in control of cardiac hypertrophy.
@en
MicroRNAs in control of cardiac hypertrophy.
@nl
type
label
MicroRNAs in control of cardiac hypertrophy.
@en
MicroRNAs in control of cardiac hypertrophy.
@nl
prefLabel
MicroRNAs in control of cardiac hypertrophy.
@en
MicroRNAs in control of cardiac hypertrophy.
@nl
P2860
P356
P1476
MicroRNAs in control of cardiac hypertrophy.
@en
P2093
Leon J De Windt
Paula A Da Costa Martins
P2860
P304
P356
10.1093/CVR/CVS013
P577
2012-01-19T00:00:00Z